Protective effects of paeoniflorin on alveolar bone resorption and soft‐tissue breakdown in experimental periodontitis
Authors:
- 14 July 2015
- journal article
- research article
- Published by Wiley in Journal of Periodontal Research
- Vol. 51 (2) , 257-264
Abstract
Background and Objective: Paeoniflorin is the main active ingredient in Radix Paeoniae and has been reported to exhibit obvious anti‐inflammatory and immune‐regulatory activities. This study aimed to investigate the protective effects of paeoniflorin on alveolar bone destruction and soft‐tissue breakdown in experimental periodontitis. As supplementary evidence, we evaluated the related expression of MMP‐2, MMP‐9, inducible nitric oxide synthase (iNOS) and cyclooxygenase‐2 (COX‐2).Material and Methods: Twenty‐eight rats were randomly placed into the following four groups: healthy group; periodontitis group; periodontitis plus 30 mg/kg of paeoniflorin (P30) group; and periodontitis plus 60 mg/kg of paeoniflorin (P60) group. Periodontitis was induced in rats by placing ligatures around the lower first molars. The body weight of each rat was measured and recorded before and after the experiment. Bone resorption was evaluated using micro‐computed tomography. Soft‐tissue destruction and collagen fiber degradation were assessed by histologic analysis and picrosirius red staining. The expression levels of MMP‐2, MMP‐9, iNOS and COX‐2 in gingiva were detected by western blotting.Results: Periodontal tissues were intact in the healthy group. Alveolar bone level was significantly reduced, and evident inflammation of soft tissues was observed in the periodontitis group. Paeoniflorin significantly prevented alveolar bone loss and inflammatory infiltration in a dose‐dependent manner. The collagen fiber fractions were significantly higher in the P30 and P60 groups than in the periodontitis group. The results of the western blot analyses revealed that both 30 and 60 mg/kg of paeoniflorin significantly down‐regulated the levels of MMP‐2, MMP‐9, iNOS and COX‐2.Conclusion: This study provides the first evidence that paeoniflorin significantly down‐regulates inflammatory infiltration and prevents alveolar bone loss and soft‐tissue destruction in experimental periodontitis. The anti‐inflammatory mechanism of paeoniflorin was further supported, in part, by its inhibitory effect on MMP‐2, MMP‐9, iNOS and COX‐2.Keywords
Funding Information
- National Natural Science Foundation Item of China (81371146)
This publication has 34 references indexed in Scilit:
- Correlation of expression and activity of matrix metalloproteinase-9 and -2 in human gingival cells of periodontitis patientsJournal of Periodontal & Implant Science, 2013
- iNOS‐Derived Nitric Oxide Stimulates Osteoclast Activity and Alveolar Bone Loss in Ligature‐Induced Periodontitis in RatsJournal of Periodontology, 2011
- Animal Models for Periodontal DiseaseBioMed Research International, 2011
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesionSeminars in Cancer Biology, 2010
- The temporal expression and localization of extracellular matrix metalloproteinase inducer (EMMPRIN) during the development of perio-dontitis in an animal modelJournal of Periodontal Research, 2010
- Cyclophilin A (CypA) is associated with the inflammatory infiltration and alveolar bone destruction in an experimental periodontitisBiochemical and Biophysical Research Communications, 2010
- Progress in matrix metalloproteinase researchMolecular Aspects of Medicine, 2008
- Non‐Steroidal Anti‐Inflammatory Drugs, Cyclooxygenase‐2 and the Bone Healing ProcessBasic & Clinical Pharmacology & Toxicology, 2007
- Protective effects of baicalin on ligature‐induced periodontitis in ratsJournal of Periodontal Research, 2007
- Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in ratsEuropean Journal of Oral Sciences, 2000